江苏新瀚新材料股份有限公司 2024年度独立董事述职报告 （黄和发） 本人黄和发在2024年度担任江苏新瀚新材料股份有限公司（以下简称"公司"） 的独立董事，根据《公司法》、《证券法》、《上市公司独立董事管理办法》、 《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运作》及 《公司章程》的规定和要求，在2024年年度工作中忠实履行独立董事的职责，积极 出席相关会议，认真审议董事会各项议案，切实维护了公司的整体利益和全体股东 特别是中小股东的合法权益。现将2024年度履行职责情况述职如下： 一、独立董事的基本情况 自 2024 年1 月1 日至2024 年12 月31 日，公司共召开股东大会 3次。本人出席 3 次。 （二）出席董事会专门委员会及独立董事专门会议情况 1、参与董事会专门委员会工作的情况 本人作为公司董事会审计委员会主任委员，2024 年度召集、主持和参加公司董事 会专门委员会具体情况如下： 1965年出生，中国国籍，无境外永久居留权，硕士学历，金融与财务管理专业， 高级会计师。1986年7月至1994年9月任安徽安庆皖西水泥厂会计、副科长；1994年 10月至1999年2月任江苏 ...

经核查独立董事黄和发先生、仇连明先生、孙志刚先生的任职经历以及签署 的相关自查文件，上述人员未在公司担任除独立董事以外的任何职务，其配偶、 父母、子女、主要社会关系也未在公司任职，也未在公司主要股东公司担任任何 职务，与公司以及主要股东之间不存在利害关系或其他可能妨碍其进行独立客观 判断的关系。因此，公司独立董事符合 上市公司独立董事管理办法》 深圳证 券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》中对独立 董事独立性的相关要求。 江苏新瀚新材料股份有限公司董事会 2025 年 4 月 25 日 江苏新瀚新材料股份有限公司 董事会关于 2024 年度独立董事独立性自查情况的专项意见 根据《 中华人民共和国公司法》 上市公司独立董事管理办法》 深圳证券交 易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等法律法规和 规范性文件及《 江苏新瀚新材料股份有限公司章程》的相关规定，江苏新瀚新材 料股份有限公司《 以下简称《 公司"）就 2024 年度在任独立董事黄和发先生、仇 连明先生、孙志刚先生提交的《 2024 年度独立董事独立性自查情况报告》进行评 估并出具如下专项意见： ...

前十大流通股东累计持有： 1998.44万股，累计占流通股比： 28.83%，较上期变化： -4.45万股。 | 名称 | 持有数量(万股) | 占总股本比例 | 增减情况(万 | | --- | --- | --- | --- | | | | (%) | 股) | | 张萍 | 699.15 | 10.08 | 不变 | | 郝国梅 | 410.18 | 5.92 | 不变 | | 叶晓明 | 300.00 | 4.33 | -30.00 | | 汤浩 | 154.21 | 2.22 | 不变 | | 滕林栋 | 96.40 | 1.39 | 7.75 | | 张泽宇 | 83.25 | 1.20 | 不变 | | 周启宝 | 81.77 | 1.18 | 3.76 | | 李康 | 74.05 | 1.07 | 新进 | | 北京银杏盛鸿投资管理有限公司-盛鸿长青私募证券 投资基金 | 56.07 | 0.81 | 新进 | | 青骊投资管理(上海)有限公司-青骊汇川3号私募证券 | | | | | 投资基金 | 43.36 | 0.63 | 新进 | | 较上个报告期退出前十大股东有 | | | | | ...

Financial Performance - The company's revenue for Q1 2025 reached ¥115,730,444.24, representing a 12.43% increase compared to ¥102,937,425.64 in the same period last year[4] - Net profit attributable to shareholders was ¥16,188,059.34, a significant increase of 47.85% from ¥10,948,940.01 year-on-year[4] - Basic earnings per share rose to ¥0.12, reflecting a 50.00% increase from ¥0.08 in the same quarter last year[4] - Net profit for the current period was ¥16,188,059.34, representing a 47.5% increase from ¥10,948,940.01 in the previous period[17] - Operating profit rose to ¥18,336,121.49, a 50.0% increase compared to ¥12,216,487.97 in the previous period[17] Cash Flow - The net cash flow from operating activities improved to ¥2,675,719.68, a remarkable increase of 242.86% compared to a negative cash flow of -¥1,873,019.37 in the previous year[4] - Cash flow from operating activities generated a net amount of ¥2,675,719.68, recovering from a negative cash flow of ¥1,873,019.37 in the previous period[19] - The company reported a net cash flow from investment activities of ¥6,779,993.96, compared to a negative cash flow of ¥29,007,990.86 in the previous period[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,265,510,987.30, up 0.93% from ¥1,253,854,801.37 at the end of the previous year[4] - The total liabilities decreased to ¥100,427,113.32 from ¥106,341,078.65, reflecting a reduction of about 5.5%[14] - The company's retained earnings increased to ¥397,775,880.18 from ¥381,587,820.84, showing a growth of approximately 4.2%[15] - The total equity attributable to the owners of the parent company rose to ¥1,165,083,873.98 from ¥1,147,513,722.72, which is an increase of about 1.5%[15] Investments and Income - The company reported a significant increase in investment income to ¥4,855,259.71, up 539.55% from ¥759,168.76 in the previous year[7] - Cash inflow from investment activities totaled ¥549,862,339.36, significantly higher than ¥112,061,267.48 in the previous period[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 16,099, with the largest shareholder holding 25.55% of the shares[9] - The total number of common shareholders at the end of the reporting period is 16,099[10] - The number of shareholders holding more than 5% of shares includes 郝国梅 with 3.05% and 4,101,809 shares[10] - The company has no preferred shareholders or changes in restricted shares during the reporting period[11] Operating Costs - Total operating costs increased to ¥101,930,395.10, up 14.1% from ¥89,407,156.76 in the previous period[16] - Management expenses rose by 56.51% to ¥10,017,590.73, mainly due to increased safety and environmental costs[7] Inventory and Receivables - Accounts receivable increased by 47.78% to ¥90,772,100.80, primarily due to outstanding customer payments within the credit period[7] - Accounts receivable rose significantly to ¥90,772,100.80 from ¥61,421,802.68, marking an increase of about 47.8%[13] - The company reported a significant increase in inventory, which decreased to ¥52,311,593.02 from ¥55,114,626.83, a decline of about 5.1%[13] Audit Information - The company did not undergo an audit for the first quarter report[21]

Financial Performance - The company's operating revenue for 2024 was ¥419,462,944.08, a decrease of 3.66% compared to ¥435,406,568.95 in 2023[18]. - Net profit attributable to shareholders for 2024 was ¥55,966,075.49, down 40.04% from ¥93,341,126.16 in 2023[18]. - Basic earnings per share for 2024 decreased to ¥0.42, down 39.13% from ¥0.69 in 2023[18]. - The company reported a weighted average return on equity of 4.96% for 2024, down from 8.62% in 2023[18]. - The company's main business revenue for the chemical new materials segment was CNY 408.63 million, a decrease of 3.39% year-on-year, with a gross margin of 24.88%, down 8.38% from the previous year[83]. - The revenue from the core raw material for specialty engineering plastics decreased by 31.32% to 175.07 million yuan in 2024, compared to 254.90 million yuan in 2023[81]. - The revenue from cosmetic raw materials increased by 77.32% to 93.58 million yuan in 2024, compared to 52.78 million yuan in 2023[81]. - The company reported a total fundraising amount of 620 million yuan, with a net amount of 554.79 million yuan raised[112]. Cash Flow and Investments - The cash flow from operating activities increased significantly to ¥139,428,467.82, a 525.70% increase from ¥22,283,603.87 in 2023[18]. - The net cash flow from operating activities increased by 525.70% year-on-year, reaching ¥139,428,467.82, primarily due to increased sales efforts and reduced inventory levels[96]. - The net cash flow from investment activities decreased by 248.53% year-on-year, resulting in a net outflow of ¥274,445,729.09, mainly due to increased idle funds in financial management[96]. - The total cash and cash equivalents decreased by 204.25% year-on-year, amounting to a net decrease of ¥152,529,899.06, primarily due to increased idle funds and trading financial assets[96]. - The company's total investment amount for the reporting period was ¥1,509,599,407.13, representing a 31.33% increase compared to ¥1,149,485,223.32 in the previous year[105]. Shareholder and Governance Matters - The company plans to distribute a cash dividend of 1.00 RMB per 10 shares, totaling 13,452,400 RMB, which represents 100% of the profit distribution[191][192]. - The company will also increase its capital by issuing 3 additional shares for every 10 shares held, based on a total share capital of 134,524,000 shares[192]. - The company held three shareholder meetings during the reporting period, ensuring compliance with legal procedures and enhancing shareholder participation through both in-person and online voting methods[145]. - The board of directors consists of 9 members, including 3 independent directors, and held seven meetings, adhering to relevant laws and regulations[146]. - The company maintains independence from its controlling shareholders in terms of assets, personnel, finance, and operations, with no instances of asset occupation or financial guarantees provided to related parties[148][151][152][153][154]. Market and Product Development - The company’s main business involves the research, production, and sales of aromatic ketone products, including specialty engineering plastics and photoinitiators[28]. - Major clients include international chemical groups such as SYENSQO, VICTREX, and EVONIK, indicating a strong market presence[29]. - The company is focusing on expanding its applications in aerospace, IT manufacturing, and biomedical sectors, leveraging the unique properties of its products[33]. - The company aims to produce 8,000 tons of aromatic ketones annually, optimizing production structure to enhance profitability and exploring new profit growth points through collaboration with downstream clients and research institutions[60]. - The company is expanding its product line in specialty engineering plastics and cosmetic raw materials, aiming for breakthroughs in product offerings[60]. Research and Development - The company has ongoing R&D projects aimed at improving product yield and purity, which are expected to create new profit growth points[93]. - The company has established a mechanism for talent development to support its expanding business needs, ensuring a skilled workforce for future growth[129]. - The company is committed to ongoing research and development in high-performance materials[163]. - The company has implemented innovative technologies that reduce emissions and enhance production safety, contributing to improved product quality and customer trust[69]. Risk Management - The company emphasizes the importance of risk awareness regarding forward-looking statements in the report, highlighting potential operational risks[4]. - The company faces risks from intensified market competition and raw material cost fluctuations, which could lead to a decline in gross margin[136]. - To mitigate gross margin risks, the company has established long-term relationships with key suppliers to secure better pricing through fixed and large-scale procurement[136]. Employee and Management Practices - The company has a comprehensive employee welfare system, including health insurance and retirement benefits, to ensure employee satisfaction and retention[189]. - The company has established a performance-based compensation system to align employee salaries with their job performance and contributions[189]. - The company has implemented a performance-based bonus system for senior management, linking bonuses to annual operational performance[196]. - The company has a structured governance system with no differential voting rights arrangements in place[159]. Future Outlook - The company provided a positive outlook for the next quarter, projecting a revenue increase of 20% to $600 million[3]. - The company plans to actively explore new international markets and develop new products to reduce reliance on export revenues[139]. - The company plans to enhance its product offerings in the cosmetic raw materials sector by seeking breakthroughs in product formulations[126].

Core Viewpoint - The company is one of the early producers of DFBP in the industry and has established partnerships with well-known PEEK manufacturers both domestically and internationally [1] Group 1: Company Overview - The company has released a notice regarding recent media reports related to the "PEEK concept sector" [1] - DFBP (4,4'-difluorobenzophenone) is a key raw material for producing PEEK products, and its market growth is closely related to the demand for PEEK in downstream applications [1] - The growth rate of DFBP is influenced by the progress of downstream expansion, which introduces significant uncertainty [1] Group 2: Market Position - The company has not identified any undisclosed significant information that may have impacted its stock trading price due to recent media reports [1]

证券代码：301076 证券简称：新瀚新材 公告编号：2025-007 江苏新瀚新材料股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、股票交易异常波动的具体情况 江苏新瀚新材料股份有限公司（以下简称"公司"）股票（证券简称：新 瀚新材，证券代码：301076）于2025年4月22日、2025年4月23日和2025年4月24 日连续三个交易日收盘价格涨幅偏离值累计超过30%，根据《深圳证券交易所 交易规则》的有关规定，属于股票交易异常波动的情形。 二、公司关注并核实相关情况的说明 针对公司股价异常波动，公司对有关事项进行了核查，并通过现场问询方 式向公司控股股东、实际控制人就相关事项进行了核实，现就有关情况说明如 下： 1、公司前期披露的信息不存在需要更正、补充之处； 2、公司关注到近期公共传媒报道了公司涉及"聚醚醚酮（PEEK）概念板块" 的相关内容。4,4'-二氟二苯酮（以下简称"DFBP"）是制备PEEK产品的关键 原料，DFBP市场增速与下游应用场景对PEEK的需求有较强的相关性，具体增速 亦受下游拓展进度影响，具 ...

分行业看，今日换手率超20%的个股中，所属基础化工行业个股最多，有6只个股上榜；计算机、汽车 等紧随其后，分别有5只、4只个股上榜。 交易所公开信息显示，今日高换手率创业板股共有8只上榜龙虎榜，买卖居前营业部中，有7股出现机构 身影，恒勃股份有3家机构专用席位上榜，合计净买入3462.25万元，新铝时代有2家机构专用席位上 榜，合计净买入2005.85万元，金凯生科有1家机构专用席位上榜，合计净买入977.19万元，新瀚新材有3 家机构专用席位上榜，合计净买入936.57万元，久祺股份有4家机构专用席位上榜，合计净买入479.44万 元，深股通现身1股龙虎榜，新铝时代获深股通净买入1302.83万元，营业部净买入居前的有天元宠物、 新瀚新材、金凯生科，净买入金额分别为7329.19万元、5686.28万元、3666.89万元，营业部净卖出居前 的是恒勃股份、新铝时代、新天地，净卖出金额分别为6573.16万元、3634.01万元、489.75万元。 资金流向方面，高换手率个股中，有11股今日获主力资金净流入，净流入金额较多的有金凯生科、飞天 诚信、新瀚新材，净流入金额分别为1.37亿元、9893.16万元、9 ...

截至4月24日收盘，PEEK材料概念上涨3.70%，位居概念板块涨幅第1，板块内，23股上涨，新瀚新材 20%涨停，中广核技、中欣氟材等涨停，富恒新材、中研股份、南京聚隆等涨幅居前，分别上涨 8.37%、6.68%、6.27%。跌幅居前的有道恩股份、天赐材料、超捷股份等，分别下跌0.88%、0.81%、 0.38%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | PEEK材料 | 3.70 | 电子身份证 | -3.20 | | 丙烯酸 | 1.89 | 华为盘古 | -3.13 | | 天津自贸区 | 1.75 | 数字货币 | -3.10 | | 宠物经济 | 1.74 | 数据安全 | -3.07 | | 维生素 | 1.35 | 云办公 | -2.98 | | 阿尔茨海默概念 | 1.30 | 智谱AI | -2.98 | | NMN概念 | 1.22 | 数据确权 | -2.94 | | 人造肉 | 1.06 | 智慧政务 | -2.92 | | CRO概念 | 0.96 | 华为鲲鹏 | -2. ...

Core Viewpoint - The special engineering plastics industry in China, particularly the production of 4,4'-difluorobenzophenone (DFBP), is experiencing rapid growth, with significant increases in production, demand, and market size projected for 2024 [1][10]. Industry Overview - DFBP is a crucial fluorinated organic fine chemical product and pharmaceutical intermediate, primarily synthesized through methods such as Friedel-Crafts acylation and diazotization oxidation [2][4]. - The upstream supply chain for DFBP includes various raw materials like fluorobenzene and hydrogen fluoride, with China being a major producer, ensuring sufficient domestic supply [4]. Demand Structure - The PEEK sector is the largest market for DFBP in China, accounting for over 90% of demand in 2024, with approximately 0.8 tons of DFBP required to produce 1 ton of PEEK [6][10]. - The medical intermediate sector is a smaller but growing application for DFBP, driven by the expanding pharmaceutical industry and aging population [8]. Market Size and Growth - In 2024, China's DFBP production is expected to reach 5,150 tons, with a demand of 3,121.3 tons and a market size of approximately 39,523.9 million yuan, translating to an average price of about 127,000 yuan per ton [10]. - The global DFBP market is projected to reach 1.175 billion yuan in 2024, with Asia and Europe accounting for 48.77% and 44.51% of the market, respectively [8]. Competitive Landscape - The DFBP market in China is highly concentrated, with leading companies like Xinhang New Materials and Zhongxin Fluorine Materials holding over 80% of the market share [12]. - Zhongxin Fluorine Materials is the largest player, capturing more than 30% of the market, followed by Xinhang New Materials and Xingfu New Materials [12]. Company Analysis - Zhongxin Fluorine Materials reported a total revenue of 1.028 billion yuan and a gross profit of 97 million yuan in the first three quarters of 2024, with a gross margin of 9.4% [14]. - Xinhang New Materials achieved a revenue of 209 million yuan in the first half of 2024, with 92 million yuan coming from its core raw materials for special engineering plastics, representing 44% of total revenue [16]. Development Trends - Future advancements in DFBP synthesis will focus on optimizing processes, developing new catalysts, and implementing automation and green technologies [18]. - Collaboration between DFBP manufacturers and downstream PEEK producers is expected to increase, enhancing product practicality and ensuring stable revenues for DFBP manufacturers [18].